Over the last decade, the nanomedicine has experienced unprecedented development in
diagnosis and management of diseases. A number of nanomedicines have been approved …

Systemic chemotherapy remains the backbone of many cancer treatments. Due to its
untargeted nature and the severe side effects it can cause, numerous nanomedicine …

More than 1050 clinical trials are registered at FDA. gov that explore multipotent
mesenchymal stromal cells (MSCs) for nearly every clinical application imaginable …

Gastrointestinal-based drug delivery is considered the preferred mode of drug
administration owing to its convenience for patients, which improves adherence. However …

Biomimetic approaches utilize natural cell membrane‐derived nanovesicles to camouflage
nanoparticles to circumvent some limitations of nanoscale materials. This emergent cell …

Reprogramming the immunosuppressive tumor microenvironment by modulating
macrophages holds great promise in tumor immunotherapy. As a class of professional …

Extracellular vesicles (EVs) have been proved a promising small interfering RNA (siRNA)
delivery vehicle to mediate gene‐silencing. Tumour‐derived extracellular vesicles (TDEVs) …

Cell membrane coating technology is an approach to the biomimetic replication of cell
membrane properties, and is an active area of ongoing research readily applicable to …

Cancer immunotherapy has received tremendous attention in the past decade owing to its
clinical successes with the use of immune‐checkpoint inhibition and chimeric antigen …

Nanoparticles (NPs) modified by cell membranes represent an emerging biomimetic
platform that can mimic the innate biological functions resulting from the various cell …